| 232. Genome-Wide Association Study of Venlafaxine Treatment Remission in Late-Life Depression V Marshe, M Maciukiewicz, S Rej, AK Tiwari, E Sibille, DM Blumberger, ... Biological Psychiatry 81 (10), S95-S96, 2017 | 3 | 2017 |
| 59 POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN K Yoshida, M Maciukiewicz, VS Marshe, AK Tiwari, EJ Brandl, ... European Neuropsychopharmacology 29, S92-S93, 2019 | | 2019 |
| A primer on the use of machine learning to distil knowledge from data in biological psychiatry TP Quinn, JL Hess, VS Marshe, MM Barnett, AC Hauschild, ... Molecular psychiatry 29 (2), 387-401, 2024 | 1 | 2024 |
| ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study L Magarbeh, C Hassel, M Choi, F Islam, VS Marshe, CC Zai, R Zuberi, ... Clinical Pharmacology & Therapeutics 114 (1), 88-117, 2023 | 6 | 2023 |
| Abstracts of Award-Winning Posters, 16th International Forum on Mood and Anxiety Disorders, Rome, December 8-10, 2016 A Janardhanan, A Sadanand, AJ Vanisree, J Gaab, AH Meyer, J Jiménez, ... Neuropsychobiology 74 (2), 84-86, 2016 | | 2016 |
| Association of СОМТ, DRD2/ANKK1, MTHFR, MIR 137, DNMT3B polymorphisms with the clinical features of schizophrenia patients in acute stage and remission HS Kandratsenka, NG Danilenko, IM Haylaenka, OA Skugarevsky, ... Doklady of the National Academy of Sciences of Belarus 65 (1), 76-86, 2021 | | 2021 |
| C-Reactive Protein and Cardiovascular Risk in Bipolar Disorder Patients: A Systematic S Rej | | 2017 |
| C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review VS Marshe, S Pira, O Mantere, B Bosche, KJ Looper, N Herrmann, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 79, 442-451, 2017 | 34 | 2017 |
| Childhood abuse history in depression predicts better response to antidepressants with higher serotonin transporter affinity: a pilot investigation LC Quilty, V Marshe, DSS Lobo, KL Harkness, DJ Müller, RM Bagby Neuropsychobiology 74 (2), 78-83, 2017 | 20 | 2017 |
| Clinical implications of APOE genotyping for late-onset Alzheimer’s disease (LOAD) risk estimation: A review of the literature VS Marshe, I Gorbovskaya, S Kanji, M Kish, DJ Müller Journal of Neural Transmission 126, 65-85, 2019 | 23 | 2019 |
| CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression X Men, ZL Taylor, VS Marshe, DM Blumberger, JF Karp, JL Kennedy, ... Clinical Pharmacology & Therapeutics 115 (5), 1065-1074, 2024 | | 2024 |
| Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study F Islam, VS Marshe, L Magarbeh, BN Frey, RV Milev, CN Soares, ... Translational psychiatry 12 (1), 366, 2022 | 16 | 2022 |
| Exploratory genome-wide analyses of cortical inhibition, facilitation, and plasticity in late-life depression RA Wathra, X Men, SSM Elsheikh, VS Marshe, TK Rajji, JI Lissemore, ... Translational psychiatry 13 (1), 234, 2023 | | 2023 |
| F120. Genome-Wide Analyses of Venlafaxine Response in Late-Life Depression D Mueller, V Marshe, M Maciukiewicz, AK Tiwari, D Blumberger, J Karp, ... Biological Psychiatry 83 (9), S284, 2018 | 1 | 2018 |
| F42POST-GWAS IN SILICO BIOLOGICAL CHARACTERIZATION OF VARIANTS ASSOCIATED WITH VENLAFAXINE TREATMENT REMISSION IN LATE-LIFE DEPRESSION V Marshe, M Maciukiewicz, AK Tiwari, E Sibille, D Blumberger, J Karp, ... European Neuropsychopharmacology 29, S1132, 2019 | | 2019 |
| F5. GENE-ENVIRONMENTAL MODIFIERS USING POLYGENIC RISK AND STRUCTURAL EQUATION MODELLING IN LATE-LIFE DEPRESSION S Elsheikh, V Marshe, G Paré, JL Kennedy, D Felsky, D Mueller European Neuropsychopharmacology 75, S222-S223, 2023 | | 2023 |
| Genetic Analyses Reveals an Association Between AaNorepinephrine Gene Promoter Variant and Remission to Venlafaxine In Late-life Depression VS Marshe, M Maciukiewicz, S Rej, AK Tiwari, E Sibille, D Blumberger, ... BIOLOGICAL PSYCHIATRY 79 (9), 130S-130S, 2016 | | 2016 |
| GENETIC AND MOLECULAR MECHANISMS IN LITHIUM ASSOCIATED RENAL DISEASE: A SYSTEMATIC REVIEW S Rej, S Pira, V Marshe, D Elie, K Looper, N Herrmann, D Mueller EUROPEAN NEUROPSYCHOPHARMACOLOGY 27, S248-S248, 2017 | | 2017 |
| Genetic similarities between compulsive overeating and addiction phenotypes: a case for “food addiction”? N Carlier, VS Marshe, J Cmorejova, C Davis, DJ Müller Current psychiatry reports 17, 1-11, 2015 | 77 | 2015 |
| Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder M Maciukiewicz, VS Marshe, AK Tiwari, TM Fonseka, N Freeman, ... Pharmacogenomics 16 (17), 1919-1929, 2015 | 21 | 2015 |
Daniel J Müller (Mueller)Professor, University of Toronto / Centre for Addiction and Mental Health在 camh.ca 的电子邮件经过验证
